Categories AlphaGraphs, Earnings, LATEST

Q4 Earnings: Gun sales miss the mark, but Smith & Wesson parent jumps 5%

With gun companies reporting sluggish sales and tapering stock prices, American Outdoor Brands (AOBC), the parent company of Smith & Wesson (SWCH), reported another quarter of dipping sales with a 24.9% decline in sales year-over-year at $172 million. Reported profit plunged 72% to $7.7 million, while on a per share basis earnings came in at $0.14 per share, down significantly from $0.50 last year. Excluding items, earnings per share fell 57.8% to $0.24.

The company has been seeing many challenges in its target markets for firearms resulting from the lower shipments and weaker demand. However, firearm background checks increased 9.1% from a year ago for the months beginning from February to April this year, reflecting an increase in demand. However, this trend does not seem to have driven American Outdoor Brands sales as evident in its results.

RELATED: Will your investment in gun stocks survive this bullet?

American Outdoor Brands provided weaker than expected guidance and said it expects first-quarter 2019 earnings per share to come in the range of $0.10-0.14, while revenue is expected in the range of $130-140 million. For the fiscal year 2019, the company expects earnings per share in the range of $0.40-$0.50, with revenue expected to come at about $570-600 million.

American Outdoor Brands fourth quarter 2018 earnings
American Outdoor Brands Corporation Q4 2018 Earnings Infographic

The Springfield, Massachusetts-based firearms firm introduced many new products through the year, which it said accounted for 29% of its firearm revenue in the fiscal year 2018. Though it saw strong adoption rate across its new products, overall sales declined, in line with industry trends.

The company’s stock has not had a good run for the last one year and has slumped more than 44%. However, the stock picked up some momentum post the results release on the results topping analyst’s earnings estimates.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top